Terms: = Endocrine gland cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Diagnosis
10 results:
1. Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary - a review.
Jung D; Almstedt K; Battista MJ; Seeger A; Jäkel J; Brenner W; Hasenburg A
J Ovarian Res; 2023 Mar; 16(1):50. PubMed ID: 36869369
[TBL] [Abstract] [Full Text] [Related]
2. Loss of tumor suppressor WWOX accelerates pancreatic cancer development through promotion of TGFβ/BMP2 signaling.
Husanie H; Abu-Remaileh M; Maroun K; Abu-Tair L; Safadi H; Atlan K; Golan T; Aqeilan RI
Cell Death Dis; 2022 Dec; 13(12):1074. PubMed ID: 36572673
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/smad3 axis and predicts a poor prognosis.
Xu C; Zhai J; Fu Y
Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
[TBL] [Abstract] [Full Text] [Related]
4. Novel Germline p.Gly42Val
Koehler VF; Jungheim K; Groß U; Iacovazzo D; Mann A; Korbonits M
Ann Clin Lab Sci; 2017 Sep; 47(5):606-610. PubMed ID: 29066490
[TBL] [Abstract] [Full Text] [Related]
5. Identification of potential biomarkers to differentially diagnose solid pseudopapillary tumors and pancreatic malignancies via a gene regulatory network.
Li P; Hu Y; Yi J; Li J; Yang J; Wang J
J Transl Med; 2015 Nov; 13():361. PubMed ID: 26578390
[TBL] [Abstract] [Full Text] [Related]
6. ARID1A gene mutation in ovarian and endometrial cancers (Review).
Takeda T; Banno K; Okawa R; Yanokura M; Iijima M; Irie-Kunitomi H; Nakamura K; Iida M; Adachi M; Umene K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
Oncol Rep; 2016 Feb; 35(2):607-13. PubMed ID: 26572704
[TBL] [Abstract] [Full Text] [Related]
7. The role of TGF-β/smad signaling in dopamine agonist-resistant prolactinomas.
Li Z; Liu Q; Li C; Zong X; Bai J; Wu Y; Lan X; Yu G; Zhang Y
Mol Cell Endocrinol; 2015 Feb; 402():64-71. PubMed ID: 25578603
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis.
Wang J; Gao J; Yao H; Wu Z; Wang M; Qi J
Tumour Biol; 2014 Jun; 35(6):6127-38. PubMed ID: 24627132
[TBL] [Abstract] [Full Text] [Related]
9. Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy.
Carey MS; Agarwal R; Gilks B; Swenerton K; Kalloger S; Santos J; Ju Z; Lu Y; Zhang F; Coombes KR; Miller D; Huntsman D; Mills GB; Hennessy BT
Clin Cancer Res; 2010 May; 16(10):2852-60. PubMed ID: 20460476
[TBL] [Abstract] [Full Text] [Related]
10. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.
Ouellet V; Guyot MC; Le Page C; Filali-Mouhim A; Lussier C; Tonin PN; Provencher DM; Mes-Masson AM
Int J Cancer; 2006 Aug; 119(3):599-607. PubMed ID: 16572426
[TBL] [Abstract] [Full Text] [Related]
